Lam Research Corporation $LRCX Stake Increased by IFP Advisors Inc

IFP Advisors Inc raised its stake in shares of Lam Research Corporation (NASDAQ:LRCXFree Report) by 24.8% during the second quarter, HoldingsChannel reports. The fund owned 21,044 shares of the semiconductor company’s stock after acquiring an additional 4,186 shares during the quarter. IFP Advisors Inc’s holdings in Lam Research were worth $9,119,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Fideuram Asset Management Ireland dac bought a new position in shares of Lam Research during the fourth quarter valued at approximately $10,035,000. Generali Investments Management Co LLC lifted its holdings in shares of Lam Research by 62.0% in the 4th quarter. Generali Investments Management Co LLC now owns 36,274 shares of the semiconductor company’s stock worth $6,209,000 after purchasing an additional 13,878 shares during the last quarter. Rokos Capital Management LLP lifted its holdings in shares of Lam Research by 42.0% in the 1st quarter. Rokos Capital Management LLP now owns 259,921 shares of the semiconductor company’s stock worth $55,532,000 after purchasing an additional 76,840 shares during the last quarter. Aware Super Pty Ltd as trustee of Aware Super acquired a new position in Lam Research during the 1st quarter valued at approximately $59,973,000. Finally, Krilogy Financial LLC grew its stake in Lam Research by 19.5% during the 1st quarter. Krilogy Financial LLC now owns 28,111 shares of the semiconductor company’s stock worth $6,006,000 after buying an additional 4,584 shares during the last quarter. Institutional investors own 84.61% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on LRCX shares. B. Riley Financial cut their target price on Lam Research from $385.00 to $350.00 and set a “buy” rating on the stock in a research note on Thursday, July 30th. UBS Group reaffirmed a “buy” rating and issued a $375.00 price objective (up from $310.00) on shares of Lam Research in a report on Tuesday, June 9th. Weiss Ratings downgraded shares of Lam Research from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, August 7th. Oppenheimer reissued an “outperform” rating and set a $400.00 target price (up from $330.00) on shares of Lam Research in a research note on Monday, June 15th. Finally, Morgan Stanley decreased their target price on shares of Lam Research from $404.00 to $367.00 and set an “overweight” rating for the company in a research report on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $358.47.

View Our Latest Research Report on Lam Research

Insider Activity at Lam Research

In other Lam Research news, Director Eric Brandt sold 54,500 shares of the company’s stock in a transaction dated Thursday, June 11th. The shares were sold at an average price of $350.80, for a total value of $19,118,600.00. Following the completion of the sale, the director directly owned 199,205 shares of the company’s stock, valued at approximately $69,881,114. This represents a 21.48% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Neil J. Fernandes sold 7,659 shares of the firm’s stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $309.60, for a total transaction of $2,371,226.40. Following the transaction, the senior vice president owned 58,470 shares of the company’s stock, valued at approximately $18,102,312. This trade represents a 11.58% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 80,441 shares of company stock valued at $27,614,296 over the last 90 days. 0.31% of the stock is currently owned by corporate insiders.

Lam Research Price Performance

Shares of NASDAQ:LRCX opened at $327.92 on Wednesday. Lam Research Corporation has a 12 month low of $94.11 and a 12 month high of $438.50. The stock has a market cap of $410.33 billion, a price-to-earnings ratio of 56.93, a PEG ratio of 1.32 and a beta of 1.84. The stock’s 50 day moving average price is $339.86 and its 200 day moving average price is $284.93. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.63 and a quick ratio of 1.91.

Lam Research (NASDAQ:LRCXGet Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.69 by $0.13. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The firm had revenue of $6.72 billion during the quarter, compared to analyst estimates of $6.66 billion. During the same period last year, the company posted $1.33 EPS. The firm’s quarterly revenue was up 30.0% on a year-over-year basis. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Equities research analysts anticipate that Lam Research Corporation will post 9.32 earnings per share for the current fiscal year.

Lam Research Company Profile

(Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Featured Stories

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.